BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35131617)

  • 1. Bioactive imidamide-based compounds targeted against nitric oxide synthase.
    Arias F; Franco-Montalban F; Romero M; Duarte J; Dora Carrión M; Encarnación Camacho M
    Bioorg Chem; 2022 Mar; 120():105637. PubMed ID: 35131617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors.
    Arias F; Franco-Montalban F; Romero M; Carrión MD; Camacho ME
    Bioorg Med Chem; 2021 Aug; 44():116294. PubMed ID: 34218000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
    Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
    Okamoto I; Abe M; Shibata K; Shimizu N; Sakata N; Katsuragi T; Tanaka K
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):716-22. PubMed ID: 10934111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of urea and thiourea kynurenamine derivatives: synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors.
    Chayah M; Carrión MD; Gallo MA; Jiménez R; Duarte J; Camacho ME
    ChemMedChem; 2015 May; 10(5):874-82. PubMed ID: 25801086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of 2-aminothiazole derivatives as inducible nitric oxide synthase inhibitor.
    Ueda S; Terauchi H; Kawasaki M; Yano A; Ido M
    Chem Pharm Bull (Tokyo); 2004 May; 52(5):634-7. PubMed ID: 15133224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible nitric oxide synthase: Good or bad?
    Lind M; Hayes A; Caprnda M; Petrovic D; Rodrigo L; Kruzliak P; Zulli A
    Biomed Pharmacother; 2017 Sep; 93():370-375. PubMed ID: 28651238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
    Cinelli MA; Li H; Pensa AV; Kang S; Roman LJ; Martásek P; Poulos TL; Silverman RB
    J Med Chem; 2015 Nov; 58(21):8694-712. PubMed ID: 26469213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide produced via neuronal NOS may impair vasodilatation in septic rat skeletal muscle.
    Gocan NC; Scott JA; Tyml K
    Am J Physiol Heart Circ Physiol; 2000 May; 278(5):H1480-9. PubMed ID: 10775125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes.
    Shen T; Zhu QX; Yang S; Ding R; Ma T; Ye LP; Wang LJ; Liang ZZ; Zhang XJ
    Toxicology; 2007 Oct; 239(3):186-94. PubMed ID: 17719164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
    Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
    Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
    Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
    Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats.
    Wang D; Wei J; Hsu K; Jau J; Lieu MW; Chao TJ; Chen HI
    J Biomed Sci; 1999 Jan; 6(1):28-35. PubMed ID: 9933740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations on synthesis and structure elucidation of novel [1,2,4]triazolo[1,2-a]pyridazine-1-thiones and their inhibitory activity against inducible nitric oxide synthase.
    Schulz U; Grossmann A; Witetschek M; Lemmerhirt C; Polzin M; Haertel B; Wanka H; Morgenstern O
    Bioorg Med Chem; 2013 Sep; 21(17):5518-31. PubMed ID: 23810674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
    Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
    J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung, spleen, and kidney are the major places for inducible nitric oxide synthase expression in endotoxic shock: role of p38 mitogen-activated protein kinase in signal transduction of inducible nitric oxide synthase expression.
    Kan W; Zhao KS; Jiang Y; Yan W; Huang Q; Wang J; Qin Q; Huang X; Wang S
    Shock; 2004 Mar; 21(3):281-7. PubMed ID: 14770043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up regulation of nitric oxide synthase-nitric oxide system in the testis of rats undergoing autoimmune orchitis.
    Jarazo-Dietrich S; Jacobo P; Pérez CV; Guazzone VA; Lustig L; Theas MS
    Immunobiology; 2012 Aug; 217(8):778-87. PubMed ID: 22672990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.
    Hagen TJ; Bergmanis AA; Kramer SW; Fok KF; Schmelzer AE; Pitzele BS; Swenton L; Jerome GM; Kornmeier CM; Moore WM; Branson LF; Connor JR; Manning PT; Currie MG; Hallinan EA
    J Med Chem; 1998 Sep; 41(19):3675-83. PubMed ID: 9733492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis.
    Chen LZ; Shu HY; Wu J; Yu YL; Ma D; Huang X; Liu MM; Liu XH; Shi JB
    Eur J Med Chem; 2021 Mar; 213():113174. PubMed ID: 33515864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase inhibitors: A comprehensive update.
    Minhas R; Bansal Y; Bansal G
    Med Res Rev; 2020 May; 40(3):823-855. PubMed ID: 31502681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.